Abstract: The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.
Type:
Grant
Filed:
December 1, 2021
Date of Patent:
February 14, 2023
Assignee:
Glyscend, Inc.
Inventors:
Thomas Henry Jozefiak, Ashish Nimgaonkar, Steven C. Polomoscanik
Abstract: The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.
Type:
Grant
Filed:
April 7, 2022
Date of Patent:
November 8, 2022
Assignee:
Glyscend, Inc.
Inventors:
Thomas Henry Jozefiak, Ashish Nimgaonkar, Steven C. Polomoscanik
Abstract: The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.
Type:
Grant
Filed:
April 7, 2022
Date of Patent:
November 8, 2022
Assignee:
Glyscend, Inc.
Inventors:
Thomas Henry Jozefiak, Ashish Nimgaonkar, Steven C. Polomoscanik
Abstract: The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.
Type:
Grant
Filed:
December 1, 2021
Date of Patent:
November 1, 2022
Assignee:
Glyscend, Inc.
Inventors:
Thomas Henry Jozefiak, Ashish Nimgaonkar, Steven C. Polomoscanik